Gilead Sciences Inc., common-size consolidated balance sheet: assets (quarterly data)
|
|
Sep 30, 2019 |
|
Jun 30, 2019 |
|
Mar 31, 2019 |
|
Dec 31, 2018 |
|
Sep 30, 2018 |
|
Jun 30, 2018 |
|
Mar 31, 2018 |
|
Dec 31, 2017 |
|
Sep 30, 2017 |
|
Jun 30, 2017 |
|
Mar 31, 2017 |
|
Dec 31, 2016 |
|
Sep 30, 2016 |
|
Jun 30, 2016 |
|
Mar 31, 2016 |
|
Dec 31, 2015 |
|
Sep 30, 2015 |
|
Jun 30, 2015 |
|
Mar 31, 2015 |
|
Dec 31, 2014 |
|
Sep 30, 2014 |
|
Jun 30, 2014 |
|
Mar 31, 2014 |
|
|
|
Cash and cash equivalents |
16.02% |
|
17.78% |
|
26.94% |
|
28.17% |
|
22.66% |
|
20.25% |
|
11.69% |
|
10.80% |
|
17.80% |
|
14.46% |
|
17.82% |
|
14.44% |
|
17.33% |
|
12.98% |
|
13.22% |
|
24.79% |
|
27.58% |
|
18.94% |
|
27.75% |
|
28.93% |
|
21.53% |
|
27.98% |
|
22.81% |
|
|
|
Short-term marketable securities |
22.63% |
|
25.22% |
|
17.47% |
|
19.08% |
|
21.61% |
|
19.41% |
|
25.01% |
|
25.50% |
|
26.10% |
|
20.55% |
|
6.64% |
|
6.43% |
|
4.34% |
|
4.54% |
|
4.20% |
|
3.39% |
|
3.45% |
|
3.05% |
|
1.72% |
|
0.29% |
|
0.37% |
|
0.22% |
|
0.23% |
|
|
|
Accounts receivable, net of allowances |
5.60% |
|
5.37% |
|
5.22% |
|
5.22% |
|
5.39% |
|
5.42% |
|
5.77% |
|
5.48% |
|
6.37% |
|
7.43% |
|
6.99% |
|
7.92% |
|
8.97% |
|
11.51% |
|
12.90% |
|
11.29% |
|
12.06% |
|
13.61% |
|
12.62% |
|
13.37% |
|
9.88% |
|
11.01% |
|
11.53% |
|
|
|
Inventories |
1.49% |
|
1.40% |
|
1.43% |
|
1.28% |
|
1.27% |
|
1.31% |
|
1.35% |
|
1.14% |
|
1.77% |
|
2.34% |
|
2.55% |
|
2.79% |
|
3.36% |
|
3.73% |
|
3.94% |
|
3.77% |
|
3.93% |
|
5.21% |
|
4.98% |
|
4.00% |
|
6.62% |
|
6.63% |
|
7.62% |
|
|
|
Deferred tax assets |
0.00% |
|
0.00% |
|
0.00% |
|
0.00% |
|
0.00% |
|
0.00% |
|
0.00% |
|
0.00% |
|
0.00% |
|
0.00% |
|
0.00% |
|
1.50% |
|
1.35% |
|
1.67% |
|
1.74% |
|
1.60% |
|
1.77% |
|
2.13% |
|
1.71% |
|
1.47% |
|
1.33% |
|
1.24% |
|
1.24% |
|
|
|
Prepaid and other current assets |
2.21% |
|
3.58% |
|
3.09% |
|
2.52% |
|
3.38% |
|
3.69% |
|
2.45% |
|
2.36% |
|
2.57% |
|
2.67% |
|
3.12% |
|
2.79% |
|
2.51% |
|
2.30% |
|
4.34% |
|
2.93% |
|
2.39% |
|
3.27% |
|
3.58% |
|
3.05% |
|
3.82% |
|
2.59% |
|
2.76% |
|
|
|
Current assets |
47.95% |
|
53.36% |
|
54.15% |
|
56.28% |
|
54.30% |
|
50.08% |
|
46.28% |
|
45.28% |
|
54.62% |
|
47.45% |
|
37.13% |
|
35.88% |
|
37.85% |
|
36.72% |
|
40.34% |
|
47.77% |
|
51.17% |
|
46.19% |
|
52.35% |
|
51.10% |
|
43.55% |
|
49.67% |
|
46.20% |
|
|
|
Property, plant and equipment, net |
7.40% |
|
6.72% |
|
6.55% |
|
6.29% |
|
5.90% |
|
5.60% |
|
5.22% |
|
4.69% |
|
4.79% |
|
5.00% |
|
5.06% |
|
5.03% |
|
4.79% |
|
5.20% |
|
5.09% |
|
4.39% |
|
4.23% |
|
4.85% |
|
4.61% |
|
4.83% |
|
5.23% |
|
4.42% |
|
4.64% |
|
|
|
Long-term deferred tax assets |
0.00% |
|
0.00% |
|
0.00% |
|
0.00% |
|
0.00% |
|
0.00% |
|
0.00% |
|
0.00% |
|
1.77% |
|
1.89% |
|
2.09% |
|
0.71% |
|
0.85% |
|
0.87% |
|
0.61% |
|
0.63% |
|
0.57% |
|
0.45% |
|
0.53% |
|
0.68% |
|
0.57% |
|
0.49% |
|
0.49% |
|
|
|
Long-term marketable securities |
3.71% |
|
4.83% |
|
3.53% |
|
2.23% |
|
3.70% |
|
8.78% |
|
12.40% |
|
15.91% |
|
20.06% |
|
25.69% |
|
34.49% |
|
35.95% |
|
34.17% |
|
31.74% |
|
27.22% |
|
22.38% |
|
18.56% |
|
15.46% |
|
8.40% |
|
4.61% |
|
4.77% |
|
2.51% |
|
1.39% |
|
|
|
Intangible assets, net |
25.13% |
|
23.97% |
|
24.57% |
|
24.72% |
|
25.37% |
|
25.24% |
|
25.70% |
|
24.33% |
|
12.90% |
|
14.19% |
|
15.18% |
|
15.74% |
|
16.58% |
|
19.43% |
|
20.77% |
|
19.77% |
|
20.64% |
|
27.22% |
|
28.36% |
|
31.94% |
|
39.20% |
|
36.88% |
|
41.70% |
|
|
|
Goodwill |
6.96% |
|
6.51% |
|
6.55% |
|
6.47% |
|
6.40% |
|
6.31% |
|
6.36% |
|
5.92% |
|
1.81% |
|
1.94% |
|
2.03% |
|
2.06% |
|
2.07% |
|
2.34% |
|
2.45% |
|
2.26% |
|
2.31% |
|
2.99% |
|
3.06% |
|
3.38% |
|
4.06% |
|
3.75% |
|
4.17% |
|
|
|
Other long-term assets |
8.85% |
|
4.61% |
|
4.65% |
|
4.01% |
|
4.33% |
|
3.99% |
|
4.04% |
|
3.87% |
|
4.04% |
|
3.85% |
|
4.01% |
|
4.63% |
|
3.68% |
|
3.69% |
|
3.51% |
|
2.81% |
|
2.50% |
|
2.83% |
|
2.69% |
|
3.45% |
|
2.62% |
|
2.28% |
|
1.41% |
|
|
|
Long-term assets |
52.05% |
|
46.64% |
|
45.85% |
|
43.72% |
|
45.70% |
|
49.92% |
|
53.72% |
|
54.72% |
|
45.38% |
|
52.55% |
|
62.87% |
|
64.12% |
|
62.15% |
|
63.28% |
|
59.66% |
|
52.23% |
|
48.83% |
|
53.81% |
|
47.65% |
|
48.90% |
|
56.45% |
|
50.33% |
|
53.80% |
|
|
|
Total assets |
100.00% |
|
100.00% |
|
100.00% |
|
100.00% |
|
100.00% |
|
100.00% |
|
100.00% |
|
100.00% |
|
100.00% |
|
100.00% |
|
100.00% |
|
100.00% |
|
100.00% |
|
100.00% |
|
100.00% |
|
100.00% |
|
100.00% |
|
100.00% |
|
100.00% |
|
100.00% |
|
100.00% |
|
100.00% |
|
100.00% |
|
Based on:
10-Q (filing date: 2019-11-05),
10-Q (filing date: 2019-08-06),
10-Q (filing date: 2019-05-08),
10-K (filing date: 2019-02-26),
10-Q (filing date: 2018-11-06),
10-Q (filing date: 2018-08-06),
10-Q (filing date: 2018-05-09),
10-K (filing date: 2018-02-27),
10-Q (filing date: 2017-11-07),
10-Q (filing date: 2017-08-07),
10-Q (filing date: 2017-05-10),
10-K (filing date: 2017-02-27),
10-Q (filing date: 2016-11-07),
10-Q (filing date: 2016-08-05),
10-Q (filing date: 2016-05-06),
10-K (filing date: 2016-02-24),
10-Q (filing date: 2015-11-04),
10-Q (filing date: 2015-08-05),
10-Q (filing date: 2015-05-08),
10-K (filing date: 2015-02-25),
10-Q (filing date: 2014-11-05),
10-Q (filing date: 2014-08-04),
10-Q (filing date: 2014-05-07).
| Balance sheet item |
Description |
The company |
| Current assets |
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. |
Gilead Sciences Inc.’s current assets as a percentage of total assets decreased from Q1 2019 to Q2 2019 and from Q2 2019 to Q3 2019. |
| Property, plant and equipment, net |
Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
Gilead Sciences Inc.’s property, plant and equipment, net as a percentage of total assets increased from Q1 2019 to Q2 2019 and from Q2 2019 to Q3 2019. |
| Long-term assets |
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. |
Gilead Sciences Inc.’s long-term assets as a percentage of total assets increased from Q1 2019 to Q2 2019 and from Q2 2019 to Q3 2019. |